Pharmaceutical Technology

JUNE 15, 2023

The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

STAT

FEBRUARY 29, 2024

CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols. Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services.

Pharmaceutical Companies 344

Pharmaceutical Companies Pharmaceutical Companies Drug Development 344

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals.

Drug Development 89

Drug Development Pharmaceutical Companies Pharmaceutical Companies Hospitals 89

STAT

OCTOBER 5, 2023

Some scientists are trying to calculate those footprints, as part of a growing effort to understand biotech and pharmaceutical companies’ contributions to climate change. What if that information also included your medicine’s carbon footprint?

Pharmaceutical Companies 290

Pharmaceutical Companies Pharmaceutical Companies Drug Development 290

European Pharmaceutical Review

NOVEMBER 14, 2023

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities.

Drug Development 93

Drug Development Pharmaceutical Companies Pharmaceutical Companies 93

PharmaTech

JANUARY 9, 2024

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals, highlights traits that a (bio)pharmaceutical company look for when identifying a CDMO to support drug development and manufacturing programs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

STAT

OCTOBER 4, 2022

The press release issued by pharmaceutical companies Eisai and Biogen on Sept. Years and years of failed Alzheimer’s trials created, and then fortified , doubts about whether drugs that attacked amyloid, a brain protein linked to Alzheimer’s disease, were a valid approach to its treatment.

Pharmaceutical Companies 288

Pharmaceutical Companies Pharmaceutical Companies Drug Development 288

STAT

MARCH 7, 2023

But he also said he saw it as an example of a drug company filling the void left by health systems that aren’t teaching doctors and trainees how to use new medicines. Continue to STAT+ to read the full story…

Medical Schools 219

Medical Schools Pharmaceutical Companies Pharmaceutical Companies Drug Development 219

STAT

JANUARY 19, 2023

In a stunning rebuke, the Food and Drug Administration accused a drugmaker of a “cascade of failures” for a litany of quality-control problems at a manufacturing plant, the latest instance in which the regulator has castigated an Indian pharmaceutical company for such lapses.

Documentation 215

Documentation Pharmaceutical Companies Pharmaceutical Companies Drug Development 215

European Pharmaceutical Review

APRIL 3, 2024

Increasing the outsourcing of manufacturing activities is helping pharmaceutical companies to focus on their core capabilities. This is contributing to a more streamlined and efficient approach to drug development, according to the report. Yet large companies are set to expand the market at a higher CAGR of 9.1

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Compounding 52

PharmaTech

JUNE 20, 2023

With so many outsourcing/insourcing options across drug development workflows, pharmaceutical companies are faced with finding the right partner to fit the needs of their unique molecule. There are criteria to consider when outweighing the benefits and risks associated with buying or building a bioanalytical lab.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

STAT

NOVEMBER 15, 2022

For the first time, many of the world’s largest pharmaceutical companies are taking concrete steps to widen access to their medicines in low and middle-income countries, but the poorest countries continue to be disproportionately overlooked, according to a new analysis.

Pharmaceutical Companies 200

Pharmaceutical Companies Pharmaceutical Companies Drug Development 200

STAT

OCTOBER 3, 2022

Food and Drug Administration established in 1982 in an effort to get medicines for hard-to-treat diseases to patients sooner than they might under the usual pathways to the marketplace. As a condition of approval, a pharmaceutical company must confirm the effectiveness of its medicine through one or more clinical trials by a certain date.

Pharmaceutical Companies 176

Pharmaceutical Companies Pharmaceutical Companies Drug Development 176

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. However, in recent years, there has been a noticeable decline in the number of these letters being issued.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Labelling Drug Development 97

Express Pharma

JANUARY 8, 2024

As patent cliffs loom for large pharmaceutical companies, they may choose to do more partnerships, merger and acquisition (M&A) deals with biotechs to enhance their drug development and innovation. Stabilising interest rates may also prompt a return for a more promising outlook.

Pharmaceutical Companies 90

Pharmaceutical Companies Pharmaceutical Companies Drug Development 90

European Pharmaceutical Review

FEBRUARY 27, 2024

Amgen drug development highlights – November 2023 In November 2023, Phase II trial results for immunotherapy tarlatamab demonstrated an ability to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer trial patients.

Biosimilars 100

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 100

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Drug Development 106

Drug Development Immunity Immunization Pharmaceutical Companies 106

Express Pharma

OCTOBER 12, 2023

Alfasigma SpA, a pharmaceutical company to acquire all issued and outstanding shares of Intercept Pharmaceuticals Inc, a biopharmaceutical company for $19 per share; Permira Advisers LLP to acquire Ergomed Plc, a provider of drug development and clinical research services for approximately $884.8

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies Drug Development 92

European Pharmaceutical Review

OCTOBER 11, 2022

The study produced by the University of Cambridge has indicated that pharmaceutical companies are increasingly leaning away from one-time transactions with contract research organisations (CRO), to preferred providers and multi-year strategic partnerships. billion to develop and manufacture one drug.

Pharmaceutical Companies 83

Pharmaceutical Companies Pharmaceutical Companies Drug Development 83

Pharmaceutical Business Review

JUNE 13, 2023

The company offers products and services to support biotechnology and pharmaceutical companies, leading academic institutions and government agencies across the world to expedite their research and drug development initiatives. The company develops anticancer gene therapy products.

Drug Development 52

Drug Development Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Leaders

JUNE 13, 2023

The company offers products and services to support biotechnology and pharmaceutical companies, leading academic institutions and government agencies across the world to expedite their research and drug development initiatives. The company develops anticancer gene therapy products.

Drug Development 52

Drug Development Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

MAY 17, 2023

FDA publishes paper on AI/ML in drug development In 2022, North America had the largest revenue share in the global pharmaceutical quality management systems market, according to the report. These solutions eliminate the need for on-premise servers and hardware, reducing IT infrastructure costs for pharmaceutical companies.

Pharmaceutical Companies 83

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 83

Pharmaceutical Technology

MAY 31, 2023

The university and Pharos have drawn up a memorandum of understanding (MoU) to use AI technology to identify potential compounds for the rapid development of treatments. The MoU allows Pharos to collaborate with the university’s researchers and gives access to its advanced drug discovery infrastructure.

Compounding 59

Compounding Data Entry Drug Development Pharmaceutical Companies 59

Pharma Marketing Network

MAY 15, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Drug Development 59

Pharma Mirror

OCTOBER 15, 2021

Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

FDA Law Blog: Biosimilars

MARCH 6, 2024

Charles assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Drug Development Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

MAY 30, 2023

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals Drug Development 52

European Pharmaceutical Review

JULY 7, 2022

Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceutical companies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. .

Research Laboratories 90

Research Laboratories Pharmaceutical Companies Pharmaceutical Companies Hospitals 90

Pharma Marketing Network

MARCH 23, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Express Pharma

MARCH 14, 2024

This not only offers lucrative opportunities for pharmaceutical companies but also presents a ray of hope for patients eagerly waiting for disease-modifying therapies.’’ The post Biomarkers becoming important for approval of ALS therapies: GlobalData appeared first on Express Pharma.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Hospitals Drug Development 103

Pharma Mirror

FEBRUARY 4, 2021

Create a pharmaceutical company that leverages the best of what the U.S. and China have to offer toward discovering and developing new oncology therapeutics, while using the smallest drug development program possible to do so. However, their dream as scientists remained at arm’s length. Their desire?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmaceutical Technology

MAY 12, 2023

Speciality pharmaceutical company SERB Pharmaceuticals has acquired exclusive US rights for bentracimab from SFJ Pharmaceuticals. SFJ Pharmaceuticals will lead the ongoing clinical trial of bentracimab.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmaceutical Technology

MARCH 1, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development Diabetes 40

Pharmaceutical Technology

MARCH 1, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development Diabetes 40

Pharmaceutical Technology

FEBRUARY 23, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Biosimilars 52

Biosimilars Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

AUGUST 9, 2023

As a highly selective BTK inhibitor, remibrutinib “has the potential to be a first-in-class, oral treatment for people living with CSU whose symptoms are refractory despite use of antihistamines,” stated Dr Shreeram Aradhye, President of Global Drug Development and Chief Medical Officer at Novartis.

Immunity 71

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 71

European Pharmaceutical Review

AUGUST 1, 2022

The DDiCT project will be co-led by Bristol Myers Squibb (BMS)’s Disability Advancement Workplace Network (DAWN) and the Global Drug Development Team. The goal is to “ensure all patient groups are reflective of the real-world population and aligned with the epidemiology of the disease studies,” a statement said.

Drug Development 111

Drug Development Pharmaceutical Companies Pharmaceutical Companies 111